Latest Insider Transactions at Pfizer Inc (PFE)
This section provides a real-time view of insider transactions for Pfizer Inc (PFE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PFIZER INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PFIZER INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 27
2021
|
Albert Bourla Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
53,925
+24.63%
|
$1,186,350
$22.35 P/Share
|
|
Feb 27
2021
|
William R Carapezzi Jr Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
16,661
-11.89%
|
$566,474
$34.07 P/Share
|
|
Feb 27
2021
|
William R Carapezzi Jr Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
21,570
+22.92%
|
$474,540
$22.35 P/Share
|
|
Feb 27
2021
|
Jennifer B. Damico SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
7,497
-16.51%
|
$254,898
$34.07 P/Share
|
|
Feb 27
2021
|
Jennifer B. Damico SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
9,886
+29.4%
|
$217,492
$22.35 P/Share
|
|
Feb 27
2021
|
Frank A Damelio Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
124,253
-10.6%
|
$4,224,602
$34.07 P/Share
|
|
Feb 27
2021
|
Frank A Damelio Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
152,785
+20.1%
|
$3,361,270
$22.35 P/Share
|
|
Feb 27
2021
|
Angela Hwang President, Global Biopharma |
SELL
Payment of exercise price or tax liability
|
Direct |
8,040
-12.25%
|
$273,360
$34.07 P/Share
|
|
Feb 27
2021
|
Angela Hwang President, Global Biopharma |
BUY
Exercise of conversion of derivative security
|
Direct |
9,886
+22.42%
|
$217,492
$22.35 P/Share
|
|
Feb 27
2021
|
Alexander R Mackenzie Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
24,731
-8.31%
|
$840,854
$34.07 P/Share
|
|
Feb 27
2021
|
Alexander R Mackenzie Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
29,838
+16.29%
|
$656,436
$22.35 P/Share
|
|
Feb 27
2021
|
Rady A Johnson Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
20,465
-11.15%
|
$695,810
$34.07 P/Share
|
|
Feb 27
2021
|
Rady A Johnson Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
25,165
+20.89%
|
$553,630
$22.35 P/Share
|
|
Feb 27
2021
|
Sally Susman Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
59,591
-16.32%
|
$2,026,094
$34.07 P/Share
|
|
Feb 27
2021
|
Sally Susman Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
71,899
+27.09%
|
$1,581,778
$22.35 P/Share
|
|
Feb 27
2021
|
John D Young Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
105,251
-9.45%
|
$3,578,534
$34.07 P/Share
|
|
Feb 27
2021
|
John D Young Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
129,419
+18.37%
|
$2,847,218
$22.35 P/Share
|
|
Feb 27
2021
|
Douglas M Lankler Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
43,855
-15.38%
|
$1,491,070
$34.07 P/Share
|
|
Feb 27
2021
|
Douglas M Lankler Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
53,925
+26.42%
|
$1,186,350
$22.35 P/Share
|
|
Feb 27
2021
|
Mikael Dolsten President R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
23,841
-14.76%
|
$786,753
$33.49 P/Share
|
|
Feb 25
2021
|
Jennifer B. Damico SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
9,571
-21.6%
|
$325,414
$34.29 P/Share
|
|
Feb 25
2021
|
Jennifer B. Damico SVP & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
3,649
+13.48%
|
-
|
|
Feb 25
2021
|
Jennifer B. Damico SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
12,477
+38.68%
|
$274,494
$22.89 P/Share
|
|
Feb 25
2021
|
Albert Bourla Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
133,928
-30.14%
|
$4,553,552
$34.29 P/Share
|
|
Feb 25
2021
|
Albert Bourla Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
163,334
+40.0%
|
$3,593,348
$22.86 P/Share
|
|
Feb 25
2021
|
William R Carapezzi Jr Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
20,601
-14.93%
|
$700,434
$34.29 P/Share
|
|
Feb 25
2021
|
William R Carapezzi Jr Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
27,222
+27.56%
|
$598,884
$22.89 P/Share
|
|
Feb 25
2021
|
Frank A Damelio Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
133,928
-11.83%
|
$4,553,552
$34.29 P/Share
|
|
Feb 25
2021
|
Frank A Damelio Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
163,334
+21.72%
|
$3,593,348
$22.89 P/Share
|
|
Feb 25
2021
|
Angela Hwang President, Global Biopharma |
SELL
Payment of exercise price or tax liability
|
Direct |
18,602
-23.39%
|
$632,468
$34.29 P/Share
|
|
Feb 25
2021
|
Angela Hwang President, Global Biopharma |
BUY
Exercise of conversion of derivative security
|
Direct |
22,686
+34.58%
|
$499,092
$22.89 P/Share
|
|
Feb 25
2021
|
Mikael Dolsten President R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
28,271
-15.29%
|
$932,943
$33.82 P/Share
|
|
Feb 25
2021
|
Rady A Johnson Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
30,793
-16.07%
|
$1,046,962
$34.29 P/Share
|
|
Feb 25
2021
|
Rady A Johnson Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
37,658
+27.17%
|
$828,476
$22.89 P/Share
|
|
Feb 25
2021
|
Douglas M Lankler Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
81,845
-24.92%
|
$2,782,730
$34.29 P/Share
|
|
Feb 25
2021
|
Douglas M Lankler Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
99,816
+35.92%
|
$2,195,952
$22.89 P/Share
|
|
Feb 25
2021
|
Alexander R Mackenzie Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
14,227
-10.33%
|
$469,491
$33.82 P/Share
|
|
Feb 25
2021
|
Alexander R Mackenzie Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
26,732
+16.25%
|
-
|
|
Feb 25
2021
|
Payal Sahni Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
7,657
-17.46%
|
$260,338
$34.29 P/Share
|
|
Feb 25
2021
|
Payal Sahni Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
9,982
+30.31%
|
$219,604
$22.89 P/Share
|
|
Feb 25
2021
|
John D Young Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
133,928
-12.02%
|
$4,553,552
$34.29 P/Share
|
|
Feb 25
2021
|
John D Young Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
163,334
+21.98%
|
$3,593,348
$22.89 P/Share
|
|
Feb 25
2021
|
Sally Susman Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
68,188
-19.19%
|
$2,318,392
$34.29 P/Share
|
|
Feb 25
2021
|
Sally Susman Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
81,667
+30.09%
|
$1,796,674
$22.89 P/Share
|
|
Feb 22
2021
|
Jennifer B. Damico SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
884
-10.8%
|
$30,056
$34.26 P/Share
|
|
Feb 22
2021
|
Payal Sahni Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,172
-8.29%
|
$39,848
$34.26 P/Share
|
|
Feb 22
2021
|
William R Carapezzi Jr Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,410
-3.08%
|
$47,940
$34.26 P/Share
|
|
Jan 31
2021
|
Lidia Fonseca Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
6,749
-14.52%
|
$236,215
$35.9 P/Share
|
|
Dec 29
2020
|
John D Young Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
10,607
-2.49%
|
$392,459
$37.05 P/Share
|
|
Dec 16
2020
|
Angela Hwang President, Global Biopharma |
BUY
Discretionary transaction
|
Indirect |
12,970
+32.7%
|
$479,890
$37.84 P/Share
|